{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:20:05Z","timestamp":1794360005506,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.seminoncol.2025.152437","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:11:38Z","timestamp":1762272698000},"page":"152437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Colchicine as an anti-inflammatory agent improving cancer prognosis: A therapeutic repurposing perspective"],"prefix":"10.1016","volume":"53","author":[{"given":"Sigal","family":"Matza Porges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3188-2707","authenticated-orcid":false,"given":"Oded","family":"Shamriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo Z","family":"Ben-Sasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seminoncol.2025.152437_bib0001","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathmechdis-032221-115501","article-title":"Innate Immunity and Cancer Pathophysiology","volume":"17","author":"Maiorino","year":"2021","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152437_bib0002","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/cei\/uxac089","article-title":"Genetics of Immune Dysregulation and Cancer Predisposition: Two Sides of the Same Coin","volume":"210","author":"Matza Porges","year":"2022","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152437_bib0003","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu Rev Immunol"},{"issue":"6024","key":"10.1016\/j.seminoncol.2025.152437_bib0004","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: Integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science (80-)"},{"issue":"7203","key":"10.1016\/j.seminoncol.2025.152437_bib0005","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152437_bib0006","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving Inflammation","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell [Internet]"},{"issue":"01322","key":"10.1016\/j.seminoncol.2025.152437_bib0007","first-page":"860","article-title":"Inflammation and Cancer","volume":"420","author":"Lisa","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.seminoncol.2025.152437_bib0008","doi-asserted-by":"crossref","unstructured":"Ozga AJ, Chow MT, Luster AD. Chemokines and the immune response to cancer. 2022;54(5):859\u201374.","DOI":"10.1016\/j.immuni.2021.01.012"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152437_bib0009","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"IL-1 and related cytokines in innate and adaptive immunity in health and disease","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity [Internet]"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152437_bib0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/imm.13486","article-title":"Pathogenetic role and clinical significance of interleukin-1\u03b2 in cancer","volume":"168","author":"Malkova","year":"2023","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152437_bib0011","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ejca.2006.01.010","article-title":"Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions","volume":"42","author":"Apte","year":"2006","journal-title":"Eur J Cancer"},{"issue":"10105","key":"10.1016\/j.seminoncol.2025.152437_bib0012","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152437_bib0013","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.23.00910","article-title":"Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial","volume":"42","author":"Garon","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.seminoncol.2025.152437_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107451","article-title":"Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 t","volume":"189","author":"Paz-Ares","year":"2024","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152437_bib0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1200\/JCO.23.00980","article-title":"Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial","volume":"42","author":"Tan","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152437_bib0016","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/imr.12614","article-title":"IL-1 and IL-1 Regulatory Pathways in Cancer Progression and Therapy","volume":"281","author":"Mantovani","year":"2019","journal-title":"Immunol Rev"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152437_bib0017","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1172\/JCI80006","article-title":"Tumor-induced myeloid deviation: When myeloid-derived suppressor cells meet tumor-Associated macrophages","volume":"125","author":"Ugel","year":"2015","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152437_bib0018","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: Triggers, Mechanisms, and Consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.seminoncol.2025.152437_bib0019","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152437_bib0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/art.40344","article-title":"Familial Mediterranean Fever and Incidence of Cancer: An Analysis of 8,534 Israeli Patients With 258,803 Person-Years","volume":"70","author":"Brenner","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.seminoncol.2025.152437_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152284","article-title":"Cancer incidence in Familial Mediterranean Fever: A retrospective analysis","volume":"63","author":"Baspinar","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"50","key":"10.1016\/j.seminoncol.2025.152437_bib0022","first-page":"1","article-title":"Colchicine significantly reduces incident cancer in gout male patients: A 12-year cohort study","volume":"94","author":"Kuo","year":"2015","journal-title":"Med (United States)"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152437_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40001-024-01836-1","article-title":"The effect of colchicine on cancer risk in patients with immune-mediated inflammatory diseases: a time-dependent study based on the Taiwan\u2019s National Health Insurance Research Database","volume":"29","author":"Yeh","year":"2024","journal-title":"Eur J Med Res"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152437_bib0024","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine-Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152437_bib0025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612824666180123110042","article-title":"Colchicine Pharmacokinetics and Mechanism of Action","volume":"24","author":"Angelidis","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152437_bib0026","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.seminoncol.2025.152437_bib0027","doi-asserted-by":"crossref","unstructured":"Fine N, Gracey E, Dimitriou I, La Rose J, Glogauer M, Rottapel R. GEF-H1 Is Required for Colchicine Inhibition of Neutrophil Rolling and Recruitment in Mouse Models of Gout. J Immunol; 205(12):3300-3310","DOI":"10.4049\/jimmunol.1900783"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152437_bib0028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1756-185X.70081","article-title":"Colchicine in Cardiovascular Disease: Mechanisms of Action and Therapeutic Potential","volume":"28","author":"Su","year":"2025","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.seminoncol.2025.152437_bib0029","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2017.12.027","article-title":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","volume":"269","author":"Mart\u00ednez","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.seminoncol.2025.152437_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114732","article-title":"CX Zhang Colchicine inhibits myocardial pyroptosis and reduces myocardial cell injury after myocardial infarction through the ESR1-PI3K-Akt-NF-\u03baB signaling pathway","volume":"156","author":"Chen","year":"2025","journal-title":"Int Immunopharmaco"},{"issue":"14","key":"10.1016\/j.seminoncol.2025.152437_bib0031","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1042\/CS20160090","article-title":"Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation","volume":"130","author":"Robertson","year":"2016","journal-title":"Clin Sci"},{"issue":"22","key":"10.1016\/j.seminoncol.2025.152437_bib0032","doi-asserted-by":"crossref","first-page":"11729","DOI":"10.1080\/07391102.2021.1965911","article-title":"The role of Colchicine on actin polymerization dynamics: as a potent anti-angiogenic factor","volume":"40","author":"Pathak","year":"2022","journal-title":"J Biomol Struct Dyn"},{"issue":"19","key":"10.1016\/j.seminoncol.2025.152437_bib0033","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202501907R","article-title":"Colchicine Modulates the Actin Cytoskeleton by Direct Binding to the Monomer and Facilitating Polymerization","volume":"39","author":"Aldogan","year":"2025","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/j.seminoncol.2025.152437_bib0034","first-page":"6269","article-title":"Anticancer effects of colchicine on hypopharyngeal cancer","volume":"37","author":"Cho","year":"2017","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152437_bib0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00917514","article-title":"Colchicine and methotrexate reduce leukocyte adherence and emigration in rat mesenteric venules","volume":"16","author":"Asako","year":"1992","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152437_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BSR20181802","article-title":"Anticancer effects and underlying mechanism of Colchicine on human gastric cancer cell lines in vitro and in vivo","volume":"39","author":"Zhang","year":"2019","journal-title":"Biosci Rep"},{"issue":"August","key":"10.1016\/j.seminoncol.2025.152437_bib0037","first-page":"1","article-title":"Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library","volume":"12","author":"Oh","year":"2022","journal-title":"Front Oncol"},{"issue":"25","key":"10.1016\/j.seminoncol.2025.152437_bib0038","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbrc.2023.09.006","article-title":"Colchicine inhibits the proliferation and promotes the apoptosis of papillary thyroid carcinoma cells likely due to the inhibitory effect on HDAC1","volume":"679","author":"Wang","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152437_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.119.014668","article-title":"Exploratory Review of the Role of Statins, Colchicine, and Aspirin for the Prevention of Radiation-Associated Cardiovascular Disease and Mortality","volume":"9","author":"Camara Planek","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152437_bib0040","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3390\/ijms25052502","article-title":"Disease Risk: Another Brick in the Wall","volume":"25","author":"Piras","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152437_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.123.033700","article-title":"Low-Dose Colchicine Ameliorates Doxorubicin Cardiotoxicity Via Promoting Autolysosome Degradation","volume":"13","author":"Peng","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.seminoncol.2025.152437_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2025.08.025","article-title":"Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis: An Exploratory Substudy of the LoDoCo2 Trial","author":"Mohammadnia","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152437_bib0043","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2337\/dc23-1825","article-title":"Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"47","author":"Roubille","year":"2024","journal-title":"Diabetes Care"},{"issue":"26","key":"10.1016\/j.seminoncol.2025.152437_bib0044","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"issue":"Oasis 9","key":"10.1016\/j.seminoncol.2025.152437_bib0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ahj.2024.06.007","article-title":"Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarction","volume":"275","author":"d\u2019Entremont","year":"2024","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152437_bib0046","first-page":"633","article-title":"Colchicine in Acute Myocardial Infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"Res Online"},{"issue":"18","key":"10.1016\/j.seminoncol.2025.152437_bib0047","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/eurheartj\/ehae208","article-title":"Low-dose colchicine for atherosclerosis: long-term safety","volume":"45","author":"Nidorf","year":"2024","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152437_bib0048","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine poisoning: The dark side of an ancient drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clin Toxicol"},{"issue":"20","key":"10.1016\/j.seminoncol.2025.152437_bib0049","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.3390\/cancers15205097","article-title":"Dose Consideration of Lenvatinib\u2019s Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine Therapy","volume":"15","author":"Lin","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:47:42Z","timestamp":1768312062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775425001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0093775425001290"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152437","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colchicine as an anti-inflammatory agent improving cancer prognosis: A therapeutic repurposing perspective","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152437"}}